Pronađeno: 21-29 / 29 radova

Autori: Babovic Nada Lj

>> Prikaži sve rezultate

Naslov Molecular targeting agents in renal cell carcinoma: Present strategies and future perspectives (Review)
Autori Bjelogrlic Snezana K  Radulovic Sinisa S  Babovic Nada Lj 
Info CURRENT PHARMACEUTICAL DESIGN, (2008), vol. 14 br. 11, str. 1058-1077
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients (Article)
Autori Konjevic Gordana M  Mirjacic-Martinovic Katarina M  Vuletic Ana M  Jovic Viktor  Jurisic Vladimir B  Babovic Nada Lj  Spuzic Ivan 
Info CLINICAL & EXPERIMENTAL METASTASIS, (2007), vol. 24 br. 1, str. 1-11
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Antimelanoma immunity in vitiligo and melanoma patients (Article)
Autori Juranic Zorica D  Stanojevic-Bakic Nevenka  Zizak Zeljko S  Babovic Nada Lj  Radovic-Kovacevic V  Stanojkovic Tatjana P  Dzodic Radan R 
Info NEOPLASMA, (2003), vol. 50 br. 4, str. 305-309
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients (Article)
Autori Jelic Svetislav B  Stamatovic Ljiljana  Vucicevic Slavko S  Petrovic Zeljko M  Kreacic Miroslav  Babovic Nada Lj  Jovanovic Natasa  Mikic Anton A  Gavrilovic Dusica 
Info EUROPEAN JOURNAL OF CANCER, (2002), vol. 38 br. 11, str. 1478-1489
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study (Article)
Autori Jelic Svetislav B  Babovic Nada Lj  Kovcin Vladimir N  Milicevic N  Milanovic Nenad  Popov Ivan P  Radosavljevic Davorin Z 
Info MELANOMA RESEARCH, (2002), vol. 12 br. 1, str. 91-98
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study (Article)
Autori Jelic Svetislav B  Babovic Nada Lj  Stamatovic Ljiljana  Kreacic Miroslav  Matkovic Suzana V  Popov Ivan P 
Info MEDICAL ONCOLOGY, (2001), vol. 18 br. 3, str. 189-195
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study (Article)
Autori Jelic Svetislav B  Mitrovic LB  Radosavljevic Davorin Z  Elezar E  Babovic Nada Lj  Kovcin Vladimir N  Tomasevic Zorica I  Kovacevic S  Gavrilovic Dusica  Radulovic Sinisa S 
Info LUNG CANCER, (2001), vol. 34 br. 1, str. 1-13
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy? (Article)
Autori Babovic Nada Lj  Jelic Svetislav B  Jovanovic V 
Info JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, (2000), vol. 19 br. 2, str. 149-154
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcoma (Article)
Autori Jelic Svetislav B  Babovic Nada Lj  Kreacic Miroslav  Matkovic Suzana V  Milanovic Nenad  Gavrilovic Dusica  Tomasevic Zoran M 
Info INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, (1999), vol. 19 br. 4, str. 129-138
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX